Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-16 Sale | 2023-11-20 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 2,500 | $28.01 | $70,025 | 117,089 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,886 | $0 | 120,975 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,886 | $0 | 120,975 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 13,621 | $0 | 130,710 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 7,457 | $9.24 | 117,089 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 5:00 pm | 2015-01-21 2024-01-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 7,457 | $0 | 117,089 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:02 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 10,179 | $0 | 122,311 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,882 | $0 | 112,132 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,882 | $0 | 112,132 (Direct) | View |
| 2018-04-17 Ownership | 2023-02-08 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 2,203 | $0 | 108,250 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 8,722 | $7.9 | 110,453 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 5:01 pm | 2014-02-05 2023-02-05 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 8,722 | $0 | 110,453 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:23 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 10,729 | $0 | 112,460 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 4,222 | $0 | 101,731 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 4,222 | $0 | 101,731 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:46 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 11,587 | $0 | 109,096 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 5:59 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 5,211 | $23.99 | 106,814 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 5:59 pm | 2021-02-21 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 9,305 | $0 | 106,814 (Direct) | View |